The American College of Obstetricians / American College of Obstetricians / /
IndustryTerm
therapy for estrogen receptor-positive breast cancer / treatment of breast cancer / treatment of patients with ovulatory dysfunction / treatment for breast cancer / treatment for premenopausal women with early breast cancer / prevention of breast cancer / treatment of postmenopausal women with early breast cancer / treatment of advanced breast cancer / treatment of estrogen-dependent disease / /
MedicalCondition
infertility / Cancer / uterine leiomyomas / primary breast cancer / endocrine-responsive early breast cancer / Clin Breast Cancer / late-stage breast cancer / estrogen receptor-positive breast cancer / early breast cancer / estrogen-dependent disease / ductal carcinoma / endometriosis / arthralgias / pain / estrogen receptor-positive tumors / ovulatory dysfunction / endometrial cancer / polycystic ovarian syndrome / polycystic ovary syndrome / cardiac disease / osteoporosis / severe endometriosis / thrombosis / advanced breast cancer / breast cancer / advanced breast carcinoma / invasive / operable breast cancer / chronic pelvic pain / /
African Union / The American College / American Society of Clinical Oncologists / American College of Obstetricians and Gynecologists / Clearance Center / Gynecologic Practice Committee / American Society of Clinical Oncology / /
ACOG COMMITTEE OPINION Number 412 • August 2008 Aromatase Inhibitors in Gynecologic Practice Committee on